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Summary
Human restingBlymphocytes enter a stateof sustained proliferationwhen incubatedwith both
mouse fibroblasticLcells stably expressingFcyRII/CDw32 and anti-CD40 antibodies . We have
explored the effects of 11 recombinant human cytokines (CKs) on induced cell proliferation and
immunoglobulin (Ig) production. Interleukin 4 (IL4) was the only CK able to enhance anti-
C1340-induced B cell multiplication as measured by enumeration of viable cells, and interferon
y (IFN-y) further stimulated this induced proliferation . IL4 enhanced the production ofIgM
and IgG by B cells and induced them to produce IgE. Combinations of114 and 11,2 resulted
in the production of large amounts of IgM and IgA . Interestingly, IFN-'y did not inhibit the
production ofIgEby cells stimulated with anti-CD40 andIL4. None of the tested CK combinations
resulted in theproduction of large quantities ofIgG . Therefore, this newculture system represents
a unique model to study isotype regulation in highly purifiedhumanB lymphocytes, in addition
to allowing the generation of long-term factor-dependent human B cell lines.
T
he maturation ofresting Blymphocytesinto Ig-secreting
cells is a highly regulated phenomenon, thought to be
coupled to considerable proliferation, which requires the par-
ticipation of antigen (Ag),' T cells, and probably accessory
cells (3) acting through cell-cell interactions via specificmem-
brane Ags and through the release of cytokines (CKs) . An
approach to understanding thephenomenainvolved in B cell
activation hasbeen made possible through the availability of
polyclonal activators includingantibodies to surfaceAgs (4)
and recombinant CKs (3) . These studies have shown that
antibodies againstthe B cellAg receptors (sIg) as well as other
non-Ig molecules can deliver activation signals to B cells. In
particular, theCD40 molecule has recently emerged as afunc-
tionally importantB cell surface Ag (5, 6) . The CD40 Ag
is a 277-amino acid glycoprotein whose 172-amino acid ex-
tracellulardomain has homology with thenervegrowth factor
receptor (7) and the55- and80-kDTNF receptors (8) . Soluble
anti-CD40 strongly enhances [3H]TdR uptake in costimu-
latedB cells and activates resting B cells as determined by
cell size increase (5, 6) . More recently, we have shown that
anti-CD40 antibodies presented on irradiated transfected L
cells stably expressing FcyRII/CDw32 induce a strong and
long-lasting proliferation of human B lymphocytes, which
allowed us to generate factor-dependent humanB cell lines
free of EBV infection (9) .
1 Abbreviations used in this paper . Ag, antigen ; CK, cytokine; GM, granu-
locyte/macrophage; rh, recombinant human .
Part ofthis work has been presented in Abstract forms at the 1990UCLA
Symposium on B lymphocyte development, March 31-April 6, Park City,
UT (1, 2).
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Thepresent work is aimed at studying the effects ofmany
differentrecombinant CKs on the proliferation andIg produc-
tion ofhumanB cells activated with anti-CD40. We show
that 114 is the soleCK able to boost theanti-CD40-induced
expansion ofB lymphocytes and that IFN-y enhances this
effect . Furthermore, IL4 inducesanti-CD40-activatedBcells
to produce IgE, and combinations of 114 and I1r2 induce
the production of large amounts of IgM and IgA .
Materials and Methods
Reagents.
￿
The anti-CD40mAb 89 was produced in the labo-
ratory (6) . The CDw32/FcyRII-transfected Ltk - cell line
(CDw32 L cells) waskindly provided byDr.K. Moore (DNAX,
Palo Alto, CA) (10) . Cell phenotype wasdetermined using FITC-
conjugated mAbs originating from Becton Dickinson&Co. (Moun-
tain View, CA) . The F(ab')2 fragments of goat anti-human IgD
andIgMwere from KallestadLaboratories, Inc. (Austin, TX). Cul-
tures were carried out in modified Iscove's medium as detailed pre-
viously (11) .
Cell Preparations and Cell Cultures.
￿
B cells were isolated from
tonsils as described earlier (12) . The isolated population expressed
>98% CD19 or CD20 (B cells) and<1% CD2 (T cells) or CD14
(monocytes). Proliferation assays wereperformed in 96-wellV -shaped
microtiter plates (CEB, Nemours, France) in which 2.5 x 10 3 ir-
radiated (7,000 rad) CDw32 L cells were added . 2.5 x 10° puri-
fied B cells were then added to cultures. Cells were pulsed with
1 pCi ['H]TdR usually at day3 and 7. [3H]TdR uptake was mea-
suredby standard liquid scintillation counting techniques after har-
vesting. In most experiments, 5 x 105 B cells in 1 ml were cul-
tured on 2.5 x 10' irradiated CDw32 L cells in 24-well plates,
for Ig production. Supernatants were harvested after 10 d and Ig
levels were determined by ELISA . Ig levels were also determined
in the supernatants of cells that had been split at various time in-
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in standard ELISA as described elsewhere (11) .
Cytokines .
￿
Each of the tested CKs was used over a wide range
of concentrations . Purified recombinant human (rh) II,1a (108
U/mg) was purchased from Genzyme (Boston,MA) and was usu-
ally used at 25 U/ml (2.5-150 U/ml) . Purified rhIL2 (3 x 106
U/ml) and rhIFN-y (107 U/mg) were purchased from Amgen
Biologicals (Thousands Oaks, CA) and were, respectively, used at
20 U/ml (1-50 U/ml) and 500 U/ml (25-1,250 U/ml) . Purified
rhIL5 was provided byR. Coffman (DNAX) . It was usually used
at 15 ng/ml, which represents five times the concentration required
for optimal growth and differentiation of human eosinophil
precursors . Purified rhII,3 (5 x 106 U/mg) and granulocyte/mac-
rophage (GM)-CSF (2 x 10 6 U/mg) were'provided by S. Tindall
(Schering-Plough Research, Bloomfield, NJ) and were usually,
respectively, used at 10 ng/ml (1-50 ng/ml) and 100 ng/ml (10-250
ng/ml), which were saturating for the growth of hematopoietic
precursors in liquid cultures or in colony assays performed in semi-
solid medium. Purified rhIL4 (derived from Escherichia coli ; 107
U/mg) was provided by P. Trotta (Schering-Plough Research) . In
most experiments, 11,4 was used at 100 U/ml (0.1-1,750 U/ml),
which provides maximal stimulation ofB cell growth in these cul-
ture conditions .
Purified E . coli-derived rhIFNa2b (2 x 109 U/ml ; Schering-
Plough Research) was usually used at 250 U/ml (50-1,000 U/ml) .
Purified rhTNF-a (2 x 107 U/mg; Genzyme) was usually used
at 5 ng/ml (1-20 ng/ml) . Purified rhIIx6 (10 7 U/mg ; Genzyme)
was usually used at 5 ng/ml (0.25-25 ng/ml) .Human 11,7, purified
from Cos 7 supernatant, was provided by F. Lee and J . Wideman
(DNAX) . It was usually used at 25U/ml (1-100 U/ml), one unit
being defined as the concentration inducing the half-maximal
proliferation of the murine pre-B clone K .
Results
Proliferation of Anti-CD40-activated B Cells in Response to
CKs . To study whetherCKs would costimulatewith cross-
linked anti-CD40 to induceB cell proliferation, purified resting
B cells were cultured onCDw32L cells with 0.5 pg/ml mAb
89 with or without 11 different recombinant CKs, each of
them used at various concentrations. [3H]TdR uptake was
measured at day 3 and 7 . Results illustrated in Fig. 1 were
pooled from several independent experiments performed under
exactly the same conditions (at day 7) and show the CK con-
centration that was found to be optimal in this assay. Results
obtained with IL4 alone represent the mean of 23 different
experiments performed over an 18-mo period. The otherCKs
used alone or in combination with IL4 have been tested in
three to five independent experiments. As illustrated in Fig.
1 A, IL4 strongly potentiated B cell proliferation . As shown
in Fig. 2 A, the 1L4-induced [ 3H]TdR uptake was optimal
at -100 U/ml, but concentrations as low as 2.5 U/ml dis-
played significant activity. IL1ca, 11,6, and IFN- ,y were also
found to enhance [3H]TdR uptake, but it was always lower
than that observed in IL4 . Their proliferative effects were
dose dependent and were maximal at, respectively, 25 U/ml,
2 ng/ml, and 250 U/ml (data not shown) . IL2 and IL3 also
weakly enhanced [3H]TdR uptake, but I1,5, 11,7, TNF-ca,
GM-CSF, and IFN-a2b did not.
As 11L4 was reproducibly a strong enhancer of B cell growth,
we tested whether the otherCKswould modulate its effects.
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Figure 1 .
￿
Proliferative response of anti-CD40-activated B lymphocytes
to CKs. 2 .5 x 104 purified B lymphocytes were seeded on 2 .5 x 103 ir-
radiatedCDw32 L cells with 0 .5 wg/mlmAb 89 with or without recom-
binant CKs. (A) Effect of a singleCK on the mAb 89-induced prolifera-
tive. (B) Effect ofa CK on the proliferation induced by the combination
ofmAb 89 and IIr4 . [3H]TdR uptake was measured at day 7 . Results are
pooled from different experiments (23 experiments for 0 and IIA; three
to five for other CKs) . [3H]TdR uptake of B cells cultured with mAb
89 without (A) or with (B) IL4 was considered as the 100% value for
each experiment, and the stimulation index for a givenCK was calculated
as the ratio ofcpm values obtained with the combination mAb 89 + CK
± 11,4 vs. mAb 89 ± IIA . 11 .1a = 25 U/ml ; IL2 = 20 U/ml; IL3
= 10 ng/ml ; IL4 = 100 U/ml ; 11,5 = 15 ng/ml ; 11,6 = 5 ng/ml ; IIT7
= 25 U/ml; TNF-a = 5 ng/ml ; GM-CSF = 100 ng/ml ; IFN-a2b =
500 IU/ml ; IFN- ,y = 250 U/ml .
Ma and IFN-,y enhanced the [3H]TdR uptake induced by
IL4 (Fig. 1 B), andmaximum stimulation was obtained with
25 and 250 U/ml, respectively. IL2,1W, and IL6 also slightly
stimulated the [3H]TdR uptake induced by the combination
of IL4 and anti-CD40 but were less efficient than 11,1ca or
IFN-y . All the other double CK combinations have been
tested and the proliferation did not exceed those obtained with
the most active CK of the pair (data not shown) .
Combinations of IL4 and anti-CD40 resulted in a 30-40-
fold increase of the input B cells after 21 d . Whereas 11,101
only marginally enhanced the increase ofB cells obtained with
11,4 and anti-CD40, IFN-,y further stimulated cell multipli-
cation, and combinations of anti-CD40, IL4, and IFN-y707
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Figure 2 .
￿
1114 induces anti-CD40-activated B cells to proliferate and
produce Ig . (A) B cell proliferation: 2.5 x 10 4 purified spleenB cells were
cultured for7 d on 2.5 x 10 3 irradiated CDw32L cells with0.5 /Ag/ml
mAb 89 and increasing concentrations of IIr4 . Cells were pulsed with
[3H]TdR for 16 h . Results aremeans ± SD of triplicates . (B) Ig produc-
tion: 5 x 105 B cells were seeded on 2.5 x 10 4 irradiated CDw32L cells
without orwith increasing concentrations of IL4 . Supernatants were har-
vested after 10 d and Ig levels were measured by ELISA . Representative
ofthreeexperiments : (/)IgG (left ordonates) : (*) IgE (right ordonates)
production . The IgM dose-response curve is similar to that of IgG (not
shown) .
Table 1 .
￿
Cytokine-induced Production of Igs by Anti-CD40-activated B Lymphocytes
Table 2 .
￿
IL-4 and Anti-CD40-dependent Normal Human
B Cell Lines Produce Igs
105 purified B cells were cultured in 500 ul on 2.5 x 104 irradiated
CDw32 L cells in the presence of0.5 JAg/ml mAb 89 without or with
100 U/ml IL-4 . Cell cultures have been split at the indicated times and
105 cells were seeded on new CDw32 L cells and new medium . Ig levels
in supernatants were determined by ELISA. Results are means of Ig levels
in duplicate cultures. Cells cultured without IL-4 did not grow beyond
14 dand Ig levels were therefore not determined . Data are representative
of five experiments.
resulted in a 80-90-fold expansion ofinputB cells (not shown) .
All the cells expressed, after 18 d, CD19, CD20, CD21, CD24,
CD37, and HLA DR, but did not express CD3, CD4, or
CD8 (data not shown) .
Ig Production of B Cells Activated by Anti-CD40 and
CKs.
￿
Purified B cells, seeded on CDw32 L cells, with or
Ig levels
105 purified B cells were cultured in 500 I,1 on 2.5 x 104 irradiated CDw32 L cells in the presence of 0.5 kg/ml mAb 89 without or with 100
U/ml IL-4 without or with the indicated CK . Supernatants were harvested after 10 d and Ig levels were determined by ELISA. Results are means
of triplicate determinations . SD are not shown as they usually represent <10% of the mean value . Data are representative of three experiments .
IL-4 IgG igA
Ig levels
Igm
ng/ml
IgE
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Figure 3 .
￿
Combinations of IL2 and IIA induce anti-CD40-activated
B cells to produce IgM and IgA . 5 x 10 5 purified B cells were cultured
on 2.5 x 104 irradiated CDw32 L cells in the presence of0 .5 Ag/mlmAb
89 and increasingconcentrations of114 ([Ql no 11,4 ; [* 110 U/ml ; [" ]
50 U/ml ; [01250 U/ml) and 11,2 . Supernatants were harvested after 10 d
and Ig levels were measured by ELISA . (A) IgM; (B) IgA . Data are repre-
sentative of two experiments .
without mAb 89, and with or without recombinant CKs,
were tested for their ability to produce Igs . As illustrated in
Table 1, crosslinking of CD40 did not result in significant
Ig production, although supernatants of cells cultured with
mAb 89 contained a few-fold more IgM and IgG than those
of cells cultured without mAb 89 . ILlcx, IL-2, IL-3, IL5,
IL6, and IFN-y only marginally altered Ig production . How-
ever, IL4 consistently stimulated IgM and IgG production .
The most striking finding was the IL4-induced production
of IgE . As shown in Fig. 2 B, the 1174-induced increase of
Ig production was dose dependent, and the plateau was ob-
tained for -100 U/ml IL4 for all three isotypes (data not
shown, for IgM) . The concentration of IL-4 inducing a half-
maximal response was practically the same for the three iso-
types (-10 U/ml for IgG and IgM; -40 U/ml for IgE) .
B cells cultured for 21 d with anti-CD40 and 11,4 continu-
ously produced the four isotypes (Table 2) .
We also tested whether the IL4-induced Ig production could
be modulated by other CKs (Table 1) . ILlct, IL-3, IL-5, IL6,
and IFN-y only weakly modulated Ig production induced
by 114 . Note in particular the lack of inhibitory effect of
IFN-y on IL4-induced IgE production . Most interestingly,
combinations of IL2 and 1174 resulted in production ofIgM
and IgA . As shown in Fig. 3, the induced IgM and IgA
productions were a function of IL2 concentration .
Discussion
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Recently, we have reported that anti-CD40 antibodies
presented on FcyRII/CDw32-transfected L cells can induce
the proliferation of resting B lymphocytes (9) . This system
is unique in that it is the first one that allows an increase
of the total number of seeded human B cells . The present
study was aimed at determininghowCKs affect the prolifer-
ation and dilerentiation of these anti-CD40-activatedB cells .
Among 11 tested recombinant CKs (ILlce to 7, GM-CSF,
TNF-a, IFN-oz2b and IFN-y), only IIA was found to strongly
costimulate with anti-CD40 to induce B cell proliferation
as measured both by [ 3H]TdR uptake and cell counts . Un-
like what was previously demonstrated with anti-IgM-
activated B cells where IL4 appears to act as a short-term
growth factor (12), the activating property of IL4 on anti-
CD40-activated B cells was long lasting . ILlcac, IL6, and
IFN-y were found to enhance [3H]TdR uptake, but the
effect was not sufficient to result in increased cell counts .
IFN-y, and to a lesser extent ILla, were found to enhance
B cell proliferation induced by IL4 and anti-CD40 . The
stimulatory effect of IFN-y on IL4/anti-CD40-induced B
cell proliferation is in accordance with our earlier results
showing that IFN-y enhances the IL-4-induced proliferation
ofB cells costimulated with anti-IgM with or without IL4
(12, 13) . It is worth pointing out that IL5 failed to enhance
the proliferation of anti-CD40-activated B cells and, there-
fore, in contrast to murine IL-5 (14), human IIT5 has never
scored positive in any of the assays measuring B cell prolifer-
ation (15) . Likewise, TNF-a and IFN-oz failed to induce the
proliferation of anti-CD40-activated B cells, whereas they have
been shown to induce the proliferation ofB lymphocytes ac-
tivated through their Ag receptors (16, 17) . Also of interest
is the virtual lack of growth-promoting activity of IL-2 on
anti-CD40-activated B cells, whereas it is at least as potent
and often more potent than IL4 in inducing [ 3H]TdR up-
take in B cells stimulated with anti-IgM or Staphylococcus aureus
Cowan (18) . IL3 was found repeatedly to provide a small
proliferation signal to anti-CD40-activated B cells, whichwe
also found with B cells costimulated with anti-IgM (T
Defrance and J. Banchereau, unpublished observations) . Fi-
nally, as observed with B cells stimulated through their Ag
receptor, IL-7 and GM-CSF were unable to induce the prolifer-
ation of anti-CD40-activated B cells.
B cells activated with anti-CD40 were found to produce
relatively little IgM, IgG, and IgA . Whereas IL1a, IL2, 11,3,
IL5, IL6, and IFN-y did not enhance the Ig production of
proliferating B cells, 11,4 was able to enhance IgM and IgG
production and to induce the production of large amounts
ofIgE. This contrasts with previous studies showing the neces-
sary role ofT cells and monocytes in IL4-induced differenti-
ation ofB cells to IgE production (19-21) . However, a direct
capacity of IL4 to induce purified human B cells to produce
IgE was recently described (22) where combined addition
of EBV and IL4 results in EBVtransformed B cell lines
producing IgE . In our present system, we have been able to
rule out a possible role for EBV by various means (9) . The
half-maximal concentrations of IL4-inducing production of
IgM, IgG, and IgE were similar. This contrasts with the con-centrations of 114 required to induce LPS-activated murine
B cells to produce IgE that are higher than those necessary
to induce IgG (23) . Interestingly, IFN-y appears unable to
inhibit the 114-induced IgE production by anti-CD40-
activated human B cells, at variance with the EBV system
(22), where IFN-y can block the IL4-independent generation
ofIgE-producingEBV cell lines . It also differs from the IL-4-
induced IgE production by mouse LPS-activatedB cells, which
is also inhibited by IFN-y (24) . The lack of inhibitory ac-
tivity of IFN-y in I1,4-induced IgE production has, how-
ever, been observed with cord blood B cells (25) . Taken to-
gether, these data suggest that IFN-ymay inhibit I174-induced
IgE production by adult mononuclear cells in an indirect
fashion . Our present observation suggests that triggering of
CD40may represent an important event in the 11,4-induced
IgE production . It remains to be established whether the ob-
served production of IgE results from the expansion of IgE-
committedB cells or from an IL4/anti-CD40-induced switch .
We presently favor the latter hypothesis, as preliminary ex-
periments have shown that naive IgD' B cells do indeed
produce IgE under these culture conditions . Our present
finding raises the question as to whether the IgE production
observed in an allogeneic T-B cell interaction (21, 26, 27) or
in the 114 activation of mononuclear cells (19, 20, 27) in-
volves triggering of the B cell CD40 Ag.
The combination of IL4 and IL-2 resulted in a strongIgM
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